David W. Gaylor

8.4k total citations · 1 hit paper
173 papers, 6.2k citations indexed

About

David W. Gaylor is a scholar working on Cancer Research, Health, Toxicology and Mutagenesis and Molecular Biology. According to data from OpenAlex, David W. Gaylor has authored 173 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Cancer Research, 49 papers in Health, Toxicology and Mutagenesis and 19 papers in Molecular Biology. Recurrent topics in David W. Gaylor's work include Carcinogens and Genotoxicity Assessment (69 papers), Effects and risks of endocrine disrupting chemicals (35 papers) and Toxic Organic Pollutants Impact (19 papers). David W. Gaylor is often cited by papers focused on Carcinogens and Genotoxicity Assessment (69 papers), Effects and risks of endocrine disrupting chemicals (35 papers) and Toxic Organic Pollutants Impact (19 papers). David W. Gaylor collaborates with scholars based in United States, Germany and Canada. David W. Gaylor's co-authors include Stepan Melnyk, S. Jill James, Stefanie Jernigan, Ralph L. Kodell, Paul Cutler, James J. Chen, Oleksandra Pavliv, William Slikker, Shannon Rose and Carole A. Kimmel and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and Journal of the American Statistical Association.

In The Last Decade

David W. Gaylor

173 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism

2004 736 citations S. Jill James, Stefanie Jernigan et al. American Journal of Clinical Nutrition profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David W. Gaylor United States	38	1.6k	1.2k	1.2k	1.0k	1.0k	173	6.2k
David M. Umbach United States	57	1.4k 0.9×	1.1k 0.9×	230 0.2×	3.0k 2.9×	1.1k 1.1×	213	10.2k
Gary D. Stoner United States	71	803 0.5×	2.4k 2.0×	470 0.4×	6.1k 5.9×	827 0.8×	334	16.1k
Shelley S. Tworoger United States	62	297 0.2×	1.5k 1.2×	415 0.3×	2.3k 2.3×	2.0k 2.0×	340	13.4k
Hélène Jacqmin‐Gadda France	45	527 0.3×	386 0.3×	589 0.5×	692 0.7×	193 0.2×	120	7.2k
Chris Gennings United States	50	4.7k 2.9×	624 0.5×	184 0.2×	795 0.8×	278 0.3×	272	9.2k
Juan R. González Spain	36	401 0.3×	256 0.2×	416 0.3×	1.2k 1.1×	940 0.9×	149	4.6k
Robert L. Smith United Kingdom	54	530 0.3×	902 0.7×	98 0.1×	3.7k 3.6×	575 0.6×	303	11.2k
Andreas Hartmann Germany	59	2.8k 1.7×	3.7k 3.0×	998 0.8×	3.1k 3.0×	306 0.3×	245	14.9k
Evangelia Ntzani Greece	31	265 0.2×	497 0.4×	149 0.1×	1.7k 1.6×	1.4k 1.4×	120	6.9k
Fred A. Wright United States	50	677 0.4×	954 0.8×	99 0.1×	3.7k 3.5×	1.8k 1.7×	195	8.2k

Countries citing papers authored by David W. Gaylor

Since Specialization

Citations

This map shows the geographic impact of David W. Gaylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Gaylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Gaylor more than expected).

Fields of papers citing papers by David W. Gaylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Gaylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Gaylor. The network helps show where David W. Gaylor may publish in the future.

Co-authorship network of co-authors of David W. Gaylor

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Gaylor. A scholar is included among the top collaborators of David W. Gaylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Gaylor. David W. Gaylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

James, S. Jill, Stepan Melnyk, George J. Fuchs, et al.. (2008). Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. American Journal of Clinical Nutrition. 89(1). 425–430. 191 indexed citations

Gaylor, David W.. (2004). Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?. Regulatory Toxicology and Pharmacology. 41(2). 128–133. 62 indexed citations

Butenhoff, John L., David W. Gaylor, John Moore, et al.. (2004). Characterization of risk for general population exposure to perfluorooctanoate. Regulatory Toxicology and Pharmacology. 39(3). 363–380. 118 indexed citations

Coleman, Elizabeth Ann, et al.. (2003). Feasibility of Exercise During Treatment for Multiple Myeloma. Cancer Nursing. 26(5). 410–419. 176 indexed citations

Gold, Lois Swirsky, David W. Gaylor, & Thomas H. Slone. (2003). Comparison of cancer risk estimates based on a variety of risk assessment methodologies. Regulatory Toxicology and Pharmacology. 37(1). 45–53. 20 indexed citations

Blair, R., Hong Fang, David W. Gaylor, & Daniel M. Sheehan. (2001). Threshold analysis of selected dose‐response data for endocrine active chemicals^Note. Apmis. 109(3). 198–208. 6 indexed citations

Kodell, Ralph L., John F. Young, Robert R. Delongchamp, et al.. (2001). A mechanistic approach to modelling the risk of liver tumours in mice exposed to fumonisin B₁in the diet. Food Additives & Contaminants. 18(3). 237–253. 12 indexed citations

Poirier, Lionel A., Daniel R. Doerge, David W. Gaylor, et al.. (1999). An FDA Review of Sulfamethazine Toxicity. Regulatory Toxicology and Pharmacology. 30(3). 217–222. 55 indexed citations

Schwetz, Bernard A. & David W. Gaylor. (1998). Alternative tests: carcinogenesis as an example.. Environmental Health Perspectives. 106(suppl 2). 467–471. 11 indexed citations

10.

Gaylor, David W., et al.. (1998). Recent Bioassay Results on Coal Tars and Benzo(a)pyrene: Implications for Risk Assessment. Regulatory Toxicology and Pharmacology. 28(2). 178–179. 4 indexed citations

11.

Gaylor, David W., et al.. (1997). Strategy for Cost-Effective Reduction of the Sum of Health Risk Estimates for Exposures to Mixtures of Toxic Substances. University of New Hampshire Scholars Repository (University of New Hampshire at Manchester). 8(3). 5. 1 indexed citations

12.

Gaylor, David W., Ronald P. Brown, Joy Cavagnaro, et al.. (1997). Health Risk Assessment Practices in the U.S. Food and Drug Administration. Regulatory Toxicology and Pharmacology. 26(3). 307–321. 12 indexed citations

13.

Gaylor, David W. & James J. Chen. (1996). Precision of Benchmark Dose Estimates for Continuous (Nonquantal) Measurements of Toxic Effects. Regulatory Toxicology and Pharmacology. 24(1). 19–23. 11 indexed citations

14.

Gaylor, David W. & Qi Zheng. (1995). Risk Assessment of Nongenotoxic Carcinogens Based upon Cell Proliferation/Death Rates in Rodents. Risk Analysis. 16(2). 221–225. 13 indexed citations

15.

Chen, James J. & David W. Gaylor. (1992). Correlations of developmental end points observed after 2,4,5‐trichlorophenoxyacetic acid exposure in mice. Teratology. 45(3). 241–246. 13 indexed citations

16.

Slikker, William & David W. Gaylor. (1990). BIOLOGICALLY-BASED DOSE-RESPONSE MODEL FOR NEUROTOXICITY RISK ASSESSMENT. Toxicological Research. 6(2). 205–213. 8 indexed citations

17.

Gaylor, David W., et al.. (1989). Chronic toxicity/carcinogenicity studies of gentian violet in fischer 344 rats: Two-generation exposure. Food and Chemical Toxicology. 27(4). 239–247. 19 indexed citations

18.

Gaylor, David W., Fred F. Kadlubar, & Robert W. West. (1988). Estimates of the risk of bladder tumor promotion by saccharin in rats. Regulatory Toxicology and Pharmacology. 8(4). 467–470. 1 indexed citations

19.

Chen, James J. & David W. Gaylor. (1986). The upper percentiles of the distribution of the logrank statistic for small numbers of tumors. Communications in Statistics - Simulation and Computation. 15(4). 991–1002. 4 indexed citations

20.

Nelson, C. J., et al.. (1979). Accuracy of birth certificate data for detecting facial cleft defects in Arkansas children.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16(2). 167–70. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact